• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).

作者信息

Teke Martha E, Sarvestani Amber Leila, Hernandez Jonathan M, Fernando Hiran C, Timmerman Robert D

机构信息

Surgical Oncology Program, National Cancer Institute, NationalInstitutesofHealth, Building 10, Room 4-3740, Bethesda, MD, 20892, USA.

Division of Thoracic Surgery, Department of Thoracic and Cardiovascular Surgery, Allegheny Health Network, Pittsburgh, PA, USA.

出版信息

Ann Surg Oncol. 2022 Aug;29(8):4686-4687. doi: 10.1245/s10434-022-11584-3. Epub 2022 May 6.

DOI:10.1245/s10434-022-11584-3
PMID:35524087
Abstract
摘要

相似文献

1
A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).一项针对I期非小细胞肺癌（NSCLC）高危患者的肺叶下切除（SR）与立体定向消融放疗（SAbR）的随机III期研究。
Ann Surg Oncol. 2022 Aug;29(8):4686-4687. doi: 10.1245/s10434-022-11584-3. Epub 2022 May 6.
2
Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?立体定向消融放疗与亚肺叶切除术对Ⅰ期非小细胞肺癌高危手术患者的疗效是否相当？
Interact Cardiovasc Thorac Surg. 2013 Nov;17(5):845-53. doi: 10.1093/icvts/ivt262. Epub 2013 Jul 30.
3
Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age.肺叶切除术与立体定向消融放疗治疗可手术的 I 期非小细胞肺癌患者：一项按年龄分层的虚拟随机 III 期试验。
Thorac Cancer. 2019 Jun;10(6):1489-1499. doi: 10.1111/1759-7714.13103. Epub 2019 May 23.
4
Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.肺叶切除术、亚肺叶切除术和立体定向消融放疗治疗老年早期非小细胞肺癌。
JAMA Surg. 2014 Dec;149(12):1244-53. doi: 10.1001/jamasurg.2014.556.
5
SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?立体定向消融放疗与局限性切除术治疗非小细胞肺癌：我们离答案更近了吗？
Curr Treat Options Oncol. 2016 Jun;17(6):27. doi: 10.1007/s11864-016-0407-3.
6
Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.立体定向消融体部放射治疗与根治性放射治疗：Ⅰ期肺癌真实世界结局比较。
Clin Oncol (R Coll Radiol). 2019 Oct;31(10):681-687. doi: 10.1016/j.clon.2019.07.013. Epub 2019 Jul 31.
7
Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada.衡量在加拿大引入立体定向消融放疗对 I 期非小细胞肺癌的人群影响。
Oncologist. 2014 Aug;19(8):880-5. doi: 10.1634/theoncologist.2013-0469. Epub 2014 Jun 20.
8
Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.立体定向消融放疗治疗有手术机会的 I 期非小细胞肺癌患者的结果。
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):348-53. doi: 10.1016/j.ijrobp.2011.06.2003. Epub 2011 Nov 19.
9
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.立体定向消融放疗联合手术治疗早期非小细胞肺癌的融合度评估：一项 2 期临床试验。
JAMA Oncol. 2019 May 1;5(5):681-688. doi: 10.1001/jamaoncol.2018.6993.
10
Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England.英国一期非小细胞肺癌行肺叶切除术与立体定向消融放疗的治疗后生存差异。
Thorax. 2020 Mar;75(3):237-243. doi: 10.1136/thoraxjnl-2018-212493. Epub 2019 Dec 26.

引用本文的文献

1
Surgery or radiotherapy for early-stage cancer study (SORT) target trial protocol: stereotactic ablative radiotherapy (SABR) with curative intent versus surgical resection for early-stage non-small cell lung cancer (NSCLC).早期癌症手术或放疗研究（SORT）目标试验方案：根治性立体定向消融放疗（SABR）与早期非小细胞肺癌（NSCLC）手术切除的对比
BMJ Open. 2025 Jul 13;15(7):e103038. doi: 10.1136/bmjopen-2025-103038.
2
A Retrospective Study on the Long-Term Outcomes of Stereotactic Ablative Radiotherapy Versus Sublobar Resection in Lung Cancer: Analysis From the Scottish Cancer Registry.立体定向消融放疗与肺癌肺叶下切除长期疗效的回顾性研究：来自苏格兰癌症登记处的分析
Cureus. 2024 Sep 22;16(9):e69927. doi: 10.7759/cureus.69927. eCollection 2024 Sep.
3

本文引用的文献

1
Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.亚肺叶切除术与立体定向体部放疗和消融治疗早期非小细胞肺癌的比较：一项国家癌症数据库研究。
J Thorac Cardiovasc Surg. 2020 Nov;160(5):1350-1357.e11. doi: 10.1016/j.jtcvs.2019.11.132. Epub 2019 Dec 26.
2
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).亚肺叶切除术与肺叶切除术治疗早期非小细胞肺癌的围手术期死亡率和发病率：一项国际、随机、III 期试验（CALGB/Alliance 140503）的事后分析。
Lancet Respir Med. 2018 Dec;6(12):915-924. doi: 10.1016/S2213-2600(18)30411-9. Epub 2018 Nov 12.
3
Stereotactic body radiation therapy for stage I medically operable non-small cell lung cancer.立体定向体部放疗治疗 I 期可手术非小细胞肺癌。
Sci Rep. 2023 Jun 27;13(1):10384. doi: 10.1038/s41598-023-37643-7.
4
Surgery versus radiotherapy in octogenarians with stage Ia non‑small cell lung cancer: propensity score matching analysis of the SEER database.80 岁以上Ⅰa 期非小细胞肺癌患者的手术与放疗：SEER 数据库的倾向评分匹配分析。
BMC Pulm Med. 2022 Nov 10;22(1):411. doi: 10.1186/s12890-022-02177-7.
5
Resect a little, resect more, irradiate or ablate-what is the best approach?少切除一点、多切除一点、进行放疗还是消融——哪种方法最佳？
J Thorac Dis. 2022 Sep;14(9):3108-3110. doi: 10.21037/jtd-22-1099.
6
Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety.邻近胸膜的肺部恶性肿瘤局部消融：中期局部疗效及安全性评估
Front Oncol. 2022 Aug 22;12:976777. doi: 10.3389/fonc.2022.976777. eCollection 2022.
7
Influence of Dexamethasone Premedication on Acute Lung Toxicity in Lung SBRT.地塞米松预处理对肺部立体定向放疗中急性肺毒性的影响
Front Oncol. 2022 Feb 28;12:837577. doi: 10.3389/fonc.2022.837577. eCollection 2022.
8
Recent advances in early stage lung cancer.早期肺癌的最新进展
J Clin Transl Res. 2021 Apr 6;7(2):163-174. eCollection 2021 Apr 22.
9
Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early-stage NSCLC patients with SBRT.三维适形放疗（3DCRT）专题辩论：我会用立体定向体部放疗（SBRT）治疗所有早期非小细胞肺癌（NSCLC）患者。
J Appl Clin Med Phys. 2019 Mar;20(3):7-13. doi: 10.1002/acm2.12545. Epub 2019 Feb 22.
10
Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances.早期非小细胞肺癌的立体定向体部放射治疗（SBRT）：当代见解与进展
J Thorac Dis. 2018 Aug;10(Suppl 21):S2451-S2464. doi: 10.21037/jtd.2018.04.52.
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial.立体定向体部放疗治疗可手术的早期肺癌：NRG 肿瘤学 RTOG 0618 试验结果。
JAMA Oncol. 2018 Sep 1;4(9):1263-1266. doi: 10.1001/jamaoncol.2018.1251.
4
Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.手术与立体定向体部放射治疗Ⅰ期非小细胞肺癌：全面综述。
Cancer. 2018 Feb 15;124(4):667-678. doi: 10.1002/cncr.31196. Epub 2017 Dec 19.
5
Meta-analysis of intentional sublobar resections versus lobectomy for early stage non-small cell lung cancer.早期非小细胞肺癌肺段切除术与肺叶切除术对比的Meta分析
Ann Cardiothorac Surg. 2014 Mar;3(2):134-41. doi: 10.3978/j.issn.2225-319X.2014.03.08.
6
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.立体定向体部放疗治疗医学上无法手术的Ⅰ期非小细胞肺癌患者的前瞻性Ⅱ期试验结果
J Clin Oncol. 2009 Jul 10;27(20):3290-6. doi: 10.1200/JCO.2008.21.5681. Epub 2009 May 4.